Hemostemix Inc. (TSXV:HEM)

Canada · Delayed Price · Currency is CAD

0.0700

-0.0050 (-6.67%)

Sep 18, 2026, 10:12 AM EST

Hemostemix Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	15	18	17	6	14	9
Market Cap Growth	-19.43%	3.39%	178.71%	-55.27%	44.06%	-70.84%
Enterprise Value	18	20	22	10	15	10
Last Close Price	0.07	0.09	0.12	0.07	0.18	0.16

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PB Ratio	-2.57	-3.53	-2.36	-0.83	-2.01	-1.79

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	-0.62	-0.72	-0.68	-0.59	-0.61	-0.28
Net Debt / Equity Ratio	-0.58	-0.57	-0.59	-0.56	-0.59	-0.24
Net Debt / EBITDA Ratio	-0.67	-0.54	-2.15	-1.78	-1.22	-0.46
Net Debt / FCF Ratio	-0.64	-0.63	-2.22	-2.93	-0.65	-0.36
Quick Ratio	0.13	0.47	0.34	0.06	0.11	0.13
Current Ratio	0.13	0.49	0.36	0.11	0.18	0.13
Return on Assets (ROA)	-534.30%	-358.00%	-188.63%	-374.39%	-397.91%	-119.93%
Return on Capital Employed (ROCE)	295.60%	596.40%	110.70%	91.10%	151.80%	72.80%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-31.23%	-26.82%	-15.39%	-41.03%	-38.40%	-66.42%
FCF Yield	-35.58%	-25.81%	-11.19%	-23.28%	-44.76%	-36.75%
Buyback Yield / Dilution	-52.41%	-71.93%	-15.22%	-17.89%	-21.81%	-78.19%